In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

We asked doctors and experts which foods have been shown to potentially decrease cancer risk. 1. Berries. Berries are rich in ...

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will ...

Another risk of smoking cigarettes is periodontal disease, otherwise known as gum disease. This is because smoking causes ...

Bispecific anti-PD1/VEGF remains one of the hottest topics in the oncology field. Click here for a detailed analysis.

Obesity is not just a cosmetic issue—it is a clinical and biological risk factor and progression driver for ovarian cancer ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...